For Once, CEO Told the Truth- Allo Lied- PSTI Not the Only Company to Expand 3D on Large Scale- 9/15/11
CEO Letter 9/15/11- GlobesNewswire- Haifa- "Pluristem has capitalized on its proprietary 3-Dimension (3D) manufacturing technology and is proud to state that it is close to being one of the few cell therapy companies with the potential ability to mass produce stem cells for the treatment of numerous diseases."
"Even if they do not license Pluristem's 3-D technology there old 2-D method makes their cost of goods and services so high there will be no way that they can compete with Pluristem's much lower price for their PLX Cell treatment. Insurance companies and the government will go with Pluristem every time as their competitors prices will be double or triple Pluristem's price. Pluristem does have a monopoly on the 3-D expansion of all MSC's like it or not!"